As the pharmacist's scope of practice grows, so does the imperative to prove economic and clinical outcomes to payers, policymakers, and the pharmaceutical industry.
Total Pharmacy
Latest News
Total Pharmacy Podcasts
All News
Advertisement
Pharmacies are evolving into vital health care providers, addressing chronic conditions and mental health while also enhancing patient care through integrated services.
This episode explores the risks necessary for successful pharmacy leaders and the inherent nature of pharmacy that makes the profession risk-averse.
Community pharmacies redefine patient care by emphasizing personalized services, using innovative models, and addressing social determinants of health for improved outcomes.
Shantel Upshaw Houston, PharmD, inspires pharmacy professionals to transform systemic challenges into collaborative solutions, emphasizing empathy, equity, and community engagement for meaningful change.
Pharmacists enhance chronic disease management through patient-focused care, utilizing strategies like medication therapy management and community partnerships.
Leading health care economist and public policy expert John C. Goodman, PhD, breaks down what various supply chain entities can expect with TrumpRx.
Pharmacists enhancing chronic disease management through personalized care, education, and community collaboration.
President Trump signed into law HR 2483, also known as the SUPPORT for Patients and Communities Reauthorization Act of 2025.
In part 3 of our interview with John C. Goodman, PhD, he discusses how TrumpRx could impact the drug supply chain—specifically PBMs.
Advertisement
Independent pharmacies face significant challenges—such as software limitations, staffing shortages, and inconsistent billing requirements—that hinder fair reimbursement for clinical services.
John C. Goodman, PhD, discusses TrumpRx’s impact on patients and pharmacies, comparing this administration’s approach with the previous Biden Administration.
John C. Goodman, PhD, senior fellow at the Independent Institute, discusses TrumpRx and its goals for patients’ OOP drug costs.
Community pharmacies are facing major barriers due to PBM practices and vertical integration, ultimately jeopardizing patient access and trust in health care.
In this episode, host Taylor Watterson, PharmD, PhD, welcomes Wesley Sparkmon, PhD, MPH, assistant professor of pharmacy sciences at Creighton University.
Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.
A conversation with NCPDP’s Rick Sage explored the lasting effects on pharmacy stemming from the record-breaking government shutdown.
Rick Sage, executive vice president of innovation and standards with the NCPDP, discusses the nuances of billing under either Medicare Part B or D.
This episode explores ongoing developments in pharmacy law, specifically for independent pharmacies and their representatives who attended the 2025 NCPA Convention & Expo.
This collaboration is designed to bring resources addressing pharmacy shortages to the fingertips of the general public.
The event will explore the importance of advocacy, gathering experts all across community pharmacy to discuss improving patient access and education.
With a new year approaching, pharmacy law experts joined Over the Counter to recap some of the key events regarding state- and federal-level PBM reform throughout 2025.
This episode explores the complex composition of a good leader within the pharmacy industry.
Through diabetes education and initiatives focused on community health care, Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, is making a difference for patients and the pharmacy profession.
Clipper F. Young, PharmD, MPH, CDCES, BC-ADM, BCGP, discusses the Touro University California, pharmacist-led Pharm2Home initiative.
Lisa Schwartz, PharmD, discusses her general opinions regarding how the predicted success of the Medicare Drug Price Negotiation Program’s future implementation.
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
3
Delgocitinib Improves Patients’ Chronic Hand Eczema
4
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
5
